#Coronary Calcium Score | Explore Tumblr posts and blogs

cmcshealth · 15 days ago

Text

Coronary Artery Bypass Graft (CABG) or Bypass Heart Surgery in India for Foreign patients

Coronary artery bypass grafting (CABG) or heart bypass surgery, is a major heart surgery performed by an expert cardiovascular thoracic surgeon to improve blood flow to the heart. It is a treatment for coronary artery disease. Coronary Artery disease is a buildup of plaque in the heart's arteries. It narrows or blocks the coronary arteries in the heart. If not treated in time it can cause a heart attack or heart failure and can be fatal. Indian cardiovascular thoracic surgeons routinely perform CABG for both Indian and foreign patients with great success.

The Symptoms of coronary artery disease (CAD)

Coronary artery disease (CAD) is caused by plaque buildup in the arteries that supply blood to the heart. This process is called atherosclerosis. CAD is also termed a "silent killer", as the patient might not notice anything is wrong until he experiences a heart attack. Following are some of the symptoms noticed by the CAD patients:

Chest pain (angina), fullness or pressure.

Fatigue.

Heart palpitations, or sensations of a racing heartbeat.

Shortness of breath (dyspnea)

Swelling in the hands or feet.

Diagnosis of coronary artery disease

Once a patient notices the above-mentioned symptoms and visits a cardiologist for further diagnosis, the cardiologist will physically examine the patient and take a brief history of the patient. People who live a sedentary lifestyle, are obese, smoke, and have irregular and unhealthy food habits are more at risk of developing coronary artery disease. The doctor will recommend the following investigations to confirm the diagnosis:

Blood tests

Blood tests can check blood sugar and cholesterol levels.

Electrocardiogram (ECG or EKG)

This quick test checks the electrical activity of the heart.

Echocardiogram

An echocardiogram or heart ultrasound uses sound waves to create pictures of the heart. This common test can show blood flow through the heart and heart valves.

Exercise stress (treadmill) test

An exercise stress echocardiogram, also known as a stress echo or echo stress test, is a noninvasive ultrasound that measures how well your heart works when it's beating fast.

Nuclear stress test

A nuclear stress test or myocardial perfusion scan, is an imaging test that uses a radioactive tracer to show how well blood flows to the heart muscle. It can help identify areas of poor blood flow or damage in the heart.

Heart CT scan

This scan determines the amount of calcium in the coronary arteries. It doesn't use contrast dye and takes about 10–15 minutes. A higher score indicates a higher likelihood of coronary heart disease.

Cardiac catheterization and angiogram

A Coronary angiogram is a diagnostic procedure performed by a trained Intervention cardiologist to ascertain if there are any blockages in the arteries of the heart ( Coronary Artery disease ) and to look for any abnormalities in heart muscles or heart valves. A coronary angiogram is also called cardiac catheterization.

Type of Coronary artery bypass graft (CABG)

The best heart surgeons in India are performing all types of coronary artery bypass grafts or bypass heart surgery to offer a tailor-made and best-suited CABG for every individual patient. Indian heart surgeons are performing the following types of CABG with at-par success rates among the best heart surgeons in the world.

On-pump coronary artery bypass graft surgery

Off-pump bypass heart surgery

Minimal Access Coronary Artery Bypass Graft (CABG)

Robot-assisted coronary artery bypass graft

Open heart bypass heart surgery

Hybrid bypass heart surgery (CABG)

CMCS Health, the best Medical Tourism company in India, selects the most experienced heart surgeons who are extensively trained for performing all types of coronary artery bypass graft ( CABG ) or bypass heart surgery. Most Indian heart surgery hospitals have the latest technologies for offering cost-effective coronary artery bypass graft ( CABG) or bypass heart surgery for Indian and International patients. The top Indian heart surgery hospitals are JCI and NABH accredited.

India is a preferred destination among foreign patients for a CABG

Today India is the number 1 destination among global medical travelers seeking coronary artery bypass graft (CABG) offshore. The lower cost, highest success rates, and prompt start of treatment ( no waiting period) have made international patients prefer India for Coronary artery bypass graft surgery. To learn more about coronary bypass heart surgery (CABG) in India, one can visit our website.

Cmcs Health is a leading medical tourism company in India. We offer medical tourism services such as finding the right doctor, the right hospital, and cost estimation for medical treatment in India for foreign patients. Some of the main countries are Bangladesh, South Africa, Egypt, Kenya, Saudi Arabia, Ethiopia, Nigeria, Uganda, Zambia, Sudan, Dubai, Namibia, Iraq, and so on. We provide free medical assistance aplastic anemia treatment cost, stomach cancer treatment, sickle cell treatment cost, the best hospital for heart valve replacement, heart valve surgery, arthroscopic surgery, bone marrow transplant cost, best liver transplant hospital, brain tumor surgery cost, cosmetic andplastic surgery, heart surgery, kidney transplant cost, spine tumor surgery,cancer treatment cost, lung transplant,liver transplant cost, top knee replacement surgeons, knee replacement surgery cost, top shoulder replacement surgeons, hip replacement surgery cost, best bone marrow hospital, etc. If you are searching for free medical and healthcare consulting to find the best hospitals and top doctors and surgeons in India for any treatment then contact us- Cmcshealth.com.

Source: https://cmcshealth1.blogspot.com/2024/10/coronary-artery-bypass-graft-cabg-or.html

0 notes

mehmetyildizmelbourne-blog · 19 days ago

Text

How Biased Media Destroyed the NHS Career of a Cardiologist and Changed My New GP’s Perspective

More doctors are coming out of the closet and stepping out, bringing us closer to a new medical era: Medicine 3.0.

A few weeks ago, I visited my local clinic for my annual tests. My usual doctor was on leave, so I had a new GP — an older, friendly gentleman. As he looked over my results, he paused, eyes wide with concern. I feared the worst. Was it cancer, said my primitive brain? But I remained silent thanks to a few deep breaths.

“Your LDL is too high,” he said, a mix of shock and urgency in his voice. My relief turned to confusion. I have always had higher LDL in the last 20 years, especially after fixing my metabolic issues like pre-diabetes and abdominal obesity, thanks to my healing keto-carnivore diet. I asked what was so alarming.

“We need to start you on cholesterol-lowering medication immediately. Listen, mate, you’re at high risk, and as your GP, it’s my responsibility,” he pressed.

“Do you mean statins?” I asked, very familiar with the topic from my studies. He looked surprised, “Yes, have you taken them before?”

I explained, “I’ve studied their effects on the brain, but I have never needed them and will not need them unless my trusted cardiologist prescribes them for me. My HDL is high, my inflammation markers are low, my fat percentage is under 12%, and my body is highly insulin-sensitive. Besides, my HbA1c is great, my coronary calcium is low, and, more importantly, my LPIR score is excellent. Why the rush?”

He snapped, eyes blazing, ‘What the heck is LPIR?! Never heard of it!’ His voice rose to a near shout, frustration evident. ‘It doesn’t matter, mate! Your LDL is through the roof, and you need statin — that’s all the cardiologists care about! We don’t go by obscure metrics. We GPs follow the rules, mate!’

His insistence felt more like a command than advice as if the guidelines were gospel and there was no room for nuance. Fortunately, I was familiar with the struggles of GPs, so I showed my empathy and compassion to him.

“Thank you for your honest opinion, sir. With all due respect, not all cardiologists think that way,” I responded calmly. His skepticism was evident. He asked, “How do you know? Name one.”

I hesitated, reluctant to expose my trusted cardiologists in Australia to the spotlight. But after a brief pause, I decided to name a public figure, the renowned Dr. Aseem Malhotra from the UK. OMG! 😡

You can read the story on my website for free.

I created an educational and interactive audie on Substack.

I also published a version for readers on Medium.

#public health #heart health #life hacks #life lessons #healthcare #self improvement

1 note · View note

johnsanun · 2 months ago

Text

A calcium score examination, also known as a coronary artery calcium (CAC) scan, is a diagnostic test used to assess the amount of calcium buildup in the coronary arteries. This buildup can be an indicator of coronary artery disease (CAD), which is a condition that can lead to heart attacks and other cardiovascular problems.

How the Calcium Score Examination Works

CT Scan: The examination involves a computed tomography (CT) scan of the chest. This scan takes detailed images of the heart and surrounding structures.

Calcium Detection: The CT scan identifies calcium deposits in the coronary arteries. Calcium deposits are a marker of atherosclerosis, which is the buildup of fatty deposits, or plaques, in the arteries.

Scoring: The amount of calcium detected is quantified into a score, known as the Agatston score. This score helps to determine the extent of calcium buildup.

Interpreting the Calcium Score

Zero Score: No detectable calcium. This generally suggests a low risk of coronary artery disease at the time of the scan.

Low Score (1-100): Small amounts of calcium. This may indicate early atherosclerosis and a moderate risk of heart disease.

Moderate Score (101-400): Significant calcium buildup. This suggests a higher risk of coronary artery disease and might warrant further investigation or preventive measures.

High Score (Over 400): Extensive calcium deposits. This indicates a high risk of coronary artery disease and often prompts more aggressive treatment or lifestyle changes.

Purpose and Benefits

Risk Assessment: The calcium score helps assess an individual’s risk of coronary artery disease, particularly when traditional risk factors (like cholesterol levels, blood pressure, family history) present a mixed picture.

Guiding Treatment: Based on the score, doctors can recommend lifestyle changes, medications, or further tests to manage heart disease risk.

Early Detection: It can detect the presence of coronary artery disease before symptoms appear, allowing for early intervention.

Considerations

Not a Standalone Test: While useful, the calcium score is just one tool among many for evaluating heart health. It’s often used in conjunction with other assessments and clinical judgment.

Radiation Exposure: The CT scan involves a small amount of radiation, but the risk is generally considered low compared to the benefits of early disease detection.

Not Suitable for Everyone: The test is usually recommended for individuals with an intermediate risk of coronary artery disease or those with unclear risk profiles. It is not typically used for people with known heart disease or very low risk.

Overall, the calcium score examination is a valuable tool for assessing heart disease risk and guiding preventive strategies, helping individuals and healthcare providers make informed decisions about heart health.

#healthcare #health and wellness

0 notes

saycegards · 1 year ago

Text

Our health insurance system is a fucking joke. Half of some peoples jobs is just saying "no :)" and then another person explains why and then they say "oh well why didn't you just say so!" When they could have just done it in the goddamn first place. IF THE PATIENT DIDNT NEED IT I WOULDNT ORDER IT WOULD I.

Yall. I hate it so much.

Prime example: I ordered a coronary artery calcium on a lady. Her insurance said no, they wouldn't cover a coronary artery calcium score, but they WOULD cover a cardiac CT angiogram..... which is a much bigger, more comprehensive test. SUCH A GODDAMN JOKE

49K notes · View notes

drforambhuta · 8 months ago

Text

Uses of Low Dose CT:

1. Lung Cancer Screening: LDCT serves as a valuable tool for screening lung cancer in high-risk individuals, such as heavy smokers. Various large-scale studies, including the National Lung Screening Trial (NLST), have shown that LDCT can detect lung cancer at earlier stages, leading to better survival rates. Its low radiation doses allow for repeated screenings over time, facilitating the detection of early-stage tumors when treatment is most effective.

2. Cardiac Imaging: LDCT is increasingly employed for cardiac imaging, encompassing coronary artery calcium scoring and coronary CT angiography (CTA). Through radiation exposure reduction, LDCT enables clinicians to evaluate coronary artery disease and cardiac anatomy with high spatial resolution, aiding in the diagnosis and management of cardiovascular conditions.

3. Pediatric Imaging: Due to children's heightened vulnerability to radiation, LDCT is preferred for pediatric imaging studies. Whether assessing congenital abnormalities, trauma, or other pediatric conditions, LDCT provides detailed anatomical information crucial for diagnosis and treatment planning while minimizing radiation doses.

4. Abdominal Imaging: LDCT is utilized for various abdominal imaging purposes, including the assessment of abdominal pain, trauma, and oncologic conditions. By optimizing scanning parameters and utilizing advanced reconstruction techniques, LDCT permits visualization of abdominal structures while reducing radiation exposure to surrounding organs and tissues.

5. Musculoskeletal Imaging: LDCT contributes to musculoskeletal imaging, particularly in evaluating fractures, joint pathology, and orthopedic conditions. With its capability to generate high-resolution images at lower radiation doses, LDCT aids in diagnosing musculoskeletal disorders while mitigating the risk of cumulative radiation exposure in patients undergoing multiple imaging studies.

There are many good hospitals in India that offer a full body health checkup including CT scans for the early detection and management of different medical conditions.

#CT scans #low dose CT #full body health checkup #regular health checkups #health checkup packages #cancer screening #cardiac imaging #pediatric imaging #abdominal imaging #musculoskeletal imaging

0 notes

drpriya · 8 months ago

Text

Low-Dose Computed Tomography (LDCT) has a range of applications across various medical specialties due to its ability to provide detailed images of internal structures with minimal radiation exposure.

Some of the key applications include:

Lung Cancer Screening: One of the primary applications of LDCT is for lung cancer screening, particularly in high-risk populations such as current or former smokers. LDCT is effective in detecting lung nodules at an early stage, which can significantly improve treatment outcomes and reduce mortality rates.

Cardiac Imaging: LDCT can be used for cardiac imaging, including coronary artery calcium scoring and assessment of coronary artery disease. It provides detailed images of the heart and coronary arteries, allowing for the detection of calcifications and plaques associated with cardiovascular disease.

Virtual Colonoscopy (CT Colonography): LDCT can be utilized for virtual colonoscopy, a non-invasive alternative to traditional colonoscopy for detecting colorectal polyps and cancers. It involves imaging of the colon and rectum using CT technology, offering high-resolution images without the need for sedation or insertion of a scope.

Abdominal and Pelvic Imaging: LDCT is commonly used for imaging the abdomen and pelvis to diagnose conditions such as abdominal pain, kidney stones, urinary tract abnormalities, and abdominal masses. It provides detailed images of abdominal organs, blood vessels, and other structures to aid in diagnosis and treatment planning.

Orthopedic Imaging: LDCT can be utilized for imaging musculoskeletal structures, including bones and joints, to diagnose fractures, bone tumors, arthritis, and other orthopedic conditions. It provides high-resolution images that help orthopedic surgeons in planning surgical procedures and evaluating treatment outcomes.

Trauma Imaging: LDCT is often used in the emergency department for rapid assessment of trauma patients, particularly those with suspected head, chest, or abdominal injuries. It allows for quick evaluation of injuries and helps guide appropriate medical management and surgical interventions.

Screening for Other Cancers: In addition to lung cancer screening, LDCT may have potential applications in screening for other cancers, such as pancreatic cancer and ovarian cancer. Research is ongoing to evaluate the effectiveness of LDCT screening for these and other cancer types.

Overall, LDCT is a versatile imaging modality with applications across multiple medical specialties, ranging from cancer screening and diagnosis to cardiovascular and musculoskeletal imaging. Its ability to provide detailed images with low radiation exposure makes it a valuable tool in modern medicine for both diagnostic and screening purposes.

Low-Dose Computed Tomography (LDCT) is primarily utilized for the detection of lung cancer, especially in high-risk populations such as current or former smokers. However, LDCT may also have potential for detecting other types of cancers, though its effectiveness in this regard varies depending on the cancer type.

Here are some cancers that have been studied in relation to LDCT:

Lung Cancer: LDCT is widely recognized as an effective screening tool for lung cancer, particularly in individuals at high risk due to smoking history or other factors. It can detect lung nodules and other suspicious lesions at an early stage, which is crucial for improving treatment outcomes and reducing mortality rates.

Pancreatic Cancer: Research has suggested that LDCT may have potential for detecting pancreatic cancer, though the evidence is less robust compared to lung cancer screening. Pancreatic cancer is challenging to detect early due to its location and lack of specific symptoms. LDCT may help identify pancreatic lesions, but further research is needed to determine its effectiveness in routine screening.

Ovarian Cancer: Ovarian cancer is another disease with a high mortality rate due to late-stage diagnosis. Some studies have explored the use of LDCT for ovarian cancer screening, but results have been mixed, and there is currently no consensus on its effectiveness for this purpose. Transvaginal ultrasound and CA-125 blood tests are more commonly used for ovarian cancer screening.

Colorectal Cancer: While LDCT is not typically used as a primary screening tool for colorectal cancer, it can be employed for virtual colonoscopy (CT colonography), which allows for non-invasive imaging of the colon and rectum to detect polyps and other abnormalities. However, traditional colonoscopy remains the gold standard for colorectal cancer screening and diagnosis.

Other Cancers: LDCT may have potential applications in detecting other cancers, such as kidney cancer, liver cancer, and adrenal gland tumors, particularly in individuals with risk factors or suspicious symptoms. However, its role in screening for these cancers is not as well-established as it is for lung cancer.

Overall, while LDCT is primarily utilized for lung cancer screening, it may have potential for detecting other cancers as well. Further research is needed to determine its effectiveness and role in routine screening for various cancer types beyond lung cancer.

Get the best treatments for various diseases and full body health checkup at the best hospitals in India.

#health #surgery #cancer #regular health checkup #routine checkups #health checkup #full body checkup #chemotherapy #radiation

0 notes

magimark1 · 9 months ago

Text

Unveiling the Wonders of CT Scans: A Closer Look at Cutting-Edge Medical Imaging

In the realm of modern medicine, technological advancements continue to revolutionize diagnosis and treatment, and one such innovation that stands at the forefront is the Computed Tomography (CT) scan. This remarkable imaging technique has transformed the way healthcare professionals visualize internal structures of the body, providing invaluable insights into various medical conditions. In this blog, we delve into the intricacies of CT scans, exploring their applications, benefits, and impact on patient care.

What is a CT Scan?

A CT scan, also known as computed tomography or CAT scan, utilizes X-ray technology and advanced computer algorithms to create detailed cross-sectional images of the body. Unlike traditional X-rays, which produce 2-dimensional images, CT scans generate 3-dimensional images that offer a comprehensive view of the internal organs, bones, tissues, and blood vessels with exceptional clarity and precision.

Applications of CT Scans

CT scans are utilized across a wide range of medical specialties and clinical scenarios, owing to their versatility and diagnostic capabilities. Some common applications of CT scans include:

Diagnosis of Trauma and Injuries: CT scans are invaluable in assessing traumatic injuries such as fractures, internal bleeding, and head trauma, enabling healthcare providers to promptly diagnose and initiate appropriate treatment.

Detection and Characterization of Tumors: CT scans play a crucial role in detecting and characterizing tumors in various parts of the body, aiding in the diagnosis, staging, and treatment planning for cancer patients.

Evaluation of Internal Organs: CT scans provide detailed images of internal organs such as the brain, lungs, liver, kidneys, and abdomen, facilitating the diagnosis and monitoring of conditions such as strokes, pulmonary embolism, liver cirrhosis, and kidney stones.

Guidance for Procedures: CT scans are used to guide minimally invasive procedures such as biopsies, needle aspirations, and catheter placements, ensuring precision and accuracy while minimizing risks to patients.

Screening and Preventive Care: CT scans may be used for screening purposes, such as lung cancer screening for high-risk individuals or coronary artery calcium scoring for assessing cardiovascular risk factors.

Benefits of CT Scans

The widespread adoption of CT scans in clinical practice can be attributed to several key benefits:

Rapid Imaging: CT scans produce images quickly, allowing for rapid diagnosis and timely intervention in emergency situations.

High Resolution: CT scans offer high-resolution images with exceptional detail, enhancing diagnostic accuracy and confidence.

Non-Invasive: CT scans are non-invasive procedures that do not require surgery or anesthesia, making them safer and more comfortable for patients compared to invasive diagnostic techniques.

Versatility: CT scans الاشعه المقطعيهcan visualize a wide range of anatomical structures and pathologies, making them a versatile tool in clinical practice.

Quantitative Analysis: Advanced CT imaging techniques allow for quantitative analysis of tissue characteristics, aiding in the assessment of disease progression and treatment response.

In conclusion, CT scans represent a remarkable milestone in medical imaging technology, empowering healthcare providers with invaluable insights into the human body's intricacies. From diagnosing trauma and detecting tumors to guiding interventions and preventive screenings, CT scans have become indispensable tools in modern healthcare. As technology continues to evolve, the future holds promise for further advancements in CT imaging, paving the way for enhanced diagnostic accuracy, improved patient outcomes, and transformative innovations in medicine.

#CT scan #الاشعه المقطعيه

0 notes

asto-labs · 9 months ago

Text

Heart Harmony: A Trendsetting Approach to Holistic Cardiovascular Wellness Testing

Introduction:

In an era where health is the new wealth, prioritizing cardiovascular well-being takes center stage. The quest for a longer, healthier life has led to a paradigm shift in heart wellness testing. Beyond traditional screenings, a new wave of comprehensive and holistic approaches is emerging, providing individuals with a more nuanced understanding of their heart health. In this article, we explore the latest trends in heart wellness testing, offering a fresh perspective on how cutting-edge technologies and holistic methodologies are reshaping the narrative around cardiovascular well-being.

The Evolution of Heart Wellness Testing:

1. Biomarker Breakthroughs: Traditional lipid panels and cholesterol tests are evolving with the introduction of advanced biomarker testing. High-sensitivity C-reactive protein (hs-CRP), lipoprotein(a), and apolipoprotein B are among the emerging biomarkers offering deeper insights into inflammation, genetic predispositions, and cardiovascular risk.

2. Genetic Cardio Profiling: Harnessing the power of genetic testing, individuals can now unveil their unique cardiovascular genetic profile. This goes beyond predicting genetic risks and delves into tailoring prevention strategies and lifestyle interventions based on an individual’s genetic predispositions.

3. Metabolic Fitness Mapping: Holistic heart wellness testing now includes a comprehensive metabolic assessment. Analyzing parameters such as insulin sensitivity, glucose metabolism, and metabolic markers, this approach provides a 360-degree view of how lifestyle factors influence heart health beyond traditional risk factors.

4. Functional Imaging Innovations: Advancements in imaging technologies, such as coronary calcium scoring and cardiac MRI, enable a more detailed and functional analysis of the heart. These techniques go beyond anatomical assessment, offering insights into cardiac function, tissue viability, and early detection of potential issues.

5. Artificial Intelligence Integration: The integration of artificial intelligence (AI) into heart wellness testing is streamlining data analysis and predictive modeling. AI algorithms can analyze vast datasets, identifying subtle patterns and correlations that may escape traditional diagnostic methods, leading to more accurate risk assessments.

The Rise of Personalized Heart Wellness Plans:

One-size-fits-all approaches are becoming obsolete in the realm of heart wellness. The trend is shifting towards personalized heart wellness plans that consider an individual’s unique physiology, genetics, lifestyle, and environmental factors. This bespoke approach allows for tailored interventions, from personalized exercise regimens to precision nutrition plans, maximizing the impact of heart health strategies.

Beyond Diagnosing Disease: Promoting Heart Resilience

The focus is expanding from merely diagnosing cardiovascular diseases to fostering heart resilience. Holistic heart wellness tests are not only about identifying risks but also empowering individuals to proactively enhance heart health. This trend aligns with a broader cultural shift towards proactive health management, encouraging people to take charge of their well-being before problems arise.

Conclusion:

The future of heart wellness testing is marked by innovation, personalization, and a holistic understanding of cardiovascular health. As these trends gain momentum, individuals have the opportunity to embark on a wellness journey that goes beyond routine check-ups, providing a comprehensive and nuanced picture of their heart health. Embracing these advancements not only empowers individuals to make informed choices but also contributes to a cultural shift towards a proactive, heart-conscious society.

#heart health Test #Tests for blockage in heart #heart Test at home #cardiac screening Test

0 notes

healthcareandconsultigblogs · 1 year ago

Text

Advancements and the Evolving Therapeutic Landscape in the Atherosclerosis Market

Atherosclerosis, a chronic cardiovascular disease characterized by the buildup of fatty plaques in arterial walls, remains a leading global health concern. The atherosclerosis market has been undergoing significant transformations in recent years, driven by a combination of factors, including increased disease prevalence, advances in diagnostics, and innovations in therapeutic approaches. In this article, we will delve into the evolving landscape of the atherosclerosis market, exploring key developments and recent advancements that are shaping the future of atherosclerosis management.

Read more about Atherosclerosis Market Dynamics at:

http://naturalpractitionermag.com/resources/health-news-wire/?rkey=20230802IO73071&filter=4462

https://smb.jessaminejournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.bogalusadailynews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.atmoreadvance.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://www.ebusinessblog.co.uk/press-release/?rkey=20230802EN73071&filter=22856

Rising Atherosclerosis Burden

The atherosclerosis market's significance is underscored by the mounting disease burden worldwide. Atherosclerosis is a major contributor to heart attacks and strokes, leading to substantial healthcare costs and mortality rates. With an aging population and a rising incidence of risk factors such as obesity and diabetes, the global disease burden is expected to continue its upward trajectory.

Read how Atherosclerosis market is rising in the upcoming years:

https://smb.tallasseetribune.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://www.healtheconomics.com/newswire?rkey=20230802IO73071&filter=21735

https://smb.claiborneprogress.net/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://diyactive.com/news/?rkey=20230802IO73071&filter=20575

https://smb.cordeledispatch.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Diagnostic Innovations

One of the cornerstones of progress in the atherosclerosis market is the remarkable advancement in diagnostic techniques. Non-invasive imaging methods, including coronary CT angiography, carotid ultrasound, and coronary calcium scoring, have revolutionized early detection. These tools enable healthcare providers to identify atherosclerotic plaques at an earlier stage, allowing for timely intervention and improved patient outcomes.

Click through the links below to find more about Atherosclerosis Diagnosis Methods:

https://smb.brewtonstandard.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.ourdavie.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://qualitysmartsolutions.com/prnewswire?rkey=20230802IO73071&filter=24122

https://smb.panolian.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.theinteriorjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Pharmacological Advancements

Pharmaceutical companies are at the forefront of innovation in atherosclerosis management. While statins remain a mainstay in cholesterol management, recent years have seen the emergence of novel drug classes. These include PCSK9 inhibitors, which work to lower LDL cholesterol levels, and RNA-targeted therapies that aim to modify lipid metabolism. These therapies provide more options for physicians to tailor treatments to individual patient needs.

To know more about Atherosclerosis Therapeutic Approches, visit:

https://smb.clemmonscourier.net/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.thecharlottegazette.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.middlesboronews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.luvernejournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://latinbusinesstoday.com/pr-newswire/?rkey=20230802IO73071&filter=11813

Anti-Inflammatory Atherosclerosis Therapies

Atherosclerosis is increasingly recognized as an inflammatory disease, and this understanding has led to the development of anti-inflammatory therapies. Medications like canakinumab have shown promise in reducing inflammation and cardiovascular events in patients with atherosclerosis. This represents a significant shift in treatment paradigms.

Read more about Atherosclerosis Interventional Procedures at:

https://smb.prentissheadlight.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://thenews.co.ro/pr-newswire/?rkey=20230802EN73071&filter=25005

https://pr.draperjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.windsorweekly.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

http://mysillylittlegang.com/prnewswire/?rkey=20230802IO73071&filter=951

Atherosclerosis Interventional Procedures

In the interventional segment of the atherosclerosis market, minimally invasive procedures have gained prominence. Techniques such as percutaneous coronary intervention (PCI), commonly referred to as angioplasty, and stent placement have become routine interventions for patients with severe atherosclerotic disease. Bioresorbable stents, designed to dissolve over time, are an exciting area of research, potentially reducing long-term complications associated with traditional stents.

Know how can Atherosclerosis be treated naturally at:

https://newsblaze.com/pr-newswire/?rkey=20230802IO73071&filter=12684

https://smb.americustimesrecorder.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

http://www.loupdargent.info/p/blog-page_24.html?rkey=20230802EN73071&filter=5206

https://financialreports.eu/news/releases/20230802en73071/

https://smb.alabamanow.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Lifestyle Modifications

Lifestyle modifications continue to play a pivotal role in atherosclerosis management. Patients are increasingly adopting healthier lifestyles through dietary changes, regular exercise, and smoking cessation. These lifestyle adjustments complement medical interventions, reflecting a shift towards a holistic approach to patient care.

Get your personalized Atherosclerosis Medicines at:

https://pr.bradfordvillebugle.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.demopolistimes.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.chillicothevoice.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://smb.southwestdailynews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

http://www.millenniummagazine.com/prnewswire?rkey=20230802IO73071&filter=13610

Atherosclerosis Personalized Medicine

Advances in genomics and biomarker discovery are paving the way for personalized medicine in atherosclerosis treatment. Tailoring therapies to an individual's genetic makeup and specific risk factors holds great promise for optimizing treatment outcomes and reducing adverse effects.

To know more about Atherosclerosis Market Competition, click:

https://smb.kenbridgevictoriadispatch.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://timebulletin.us/pr-newswire/?rkey=20230802IO73071&filter=25020

https://smb.theleesvilleleader.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://media.newswire.ca/forefrontmedianews.html?rkey=20230802IO73071&filter=20509

https://smb.lowndessignal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Market Competition

The atherosclerosis market is fiercely competitive, with major pharmaceutical companies vying for market share. Industry giants such as Novartis, Amgen, and Pfizer are continuously investing in research and development to stay ahead in the quest for innovative therapies and medications.

Click to know more about Atherosclerosis Market challenges:

https://pr.ashlandtownnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://bambuup.com/news-by-prnewswire?rkey=20230802IO73071&filter=23620

https://www.runthemoney.com/news?rkey=20230802IO73071&filter=21853

https://smb.beauregardnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pleasuretrap.org/pr-newswire/?rkey=20230802IO73071&filter=24899

https://go.chinesewire.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Atherosclerosis Market Challenges

Despite the remarkable progress made in atherosclerosis management, the market faces several challenges. Among these are drug pricing pressures, reimbursement issues, and the ongoing need for long-term patient adherence to treatment regimens. Overcoming these hurdles is essential for sustainable growth and improved patient care.

Know how the Atherosclerosis Market is emerging over the upcoming years:

https://smb.gatescountyindex.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.midvalejournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.timesofsandiego.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://industry-news.biz/pr-newswire/?rkey=20230802IO73071&filter=25107

https://pr.greenvillebusinessmag.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.naticktownnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

Global Expansion and Emerging Atherosclerosis Markets

While atherosclerosis has traditionally been associated with developed countries, emerging markets in Asia, Latin America, and the Middle East are experiencing a surge in atherosclerotic diseases. This presents a substantial growth opportunity for companies willing to expand their presence and cater to the unique needs of these regions.

Click to know more about Atherosclerosis Market Trends, Drivers, Barriers, Companies Working, and Therapies involved at:

https://mahalsa.co.uk/pr-newswire/?rkey=20230802EN73071&filter=25062

https://thebritishclub.co.uk/pr-newswire/?rkey=20230802EN73071&filter=25048

https://americantalk.live/pr-newswire/?rkey=20230802IO73071&filter=25030

https://pr.chestercounty.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://sheinformed.com/prnewswire/?rkey=20230802IO73071&filter=15249

The atherosclerosis market has evolved significantly, driven by a growing disease burden, advances in diagnostics, and innovative therapeutic approaches. Recent developments, including the rise of anti-inflammatory therapies and personalized medicine, are reshaping the landscape of atherosclerosis management. Minimally invasive interventional procedures and lifestyle modifications also contribute to improved patient outcomes. However, challenges such as market competition and pricing pressures persist. As the industry continues to invest in research and development, the atherosclerosis market is set to remain dynamic and vital in the ongoing battle against cardiovascular disease. It is through these advancements that we inch closer to a future where atherosclerosis poses less of a threat to global health.

Read more about atherosclerosis market outlook 2032, by clicking below the informative articles:

https://pr.washingtoncitypaper.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.rivertonjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.franklintownnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.cottonwoodheightsjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.southsaltlakejournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://route249.com/pr-newswire/?rkey=20230802IO73071&filter=15366

https://aboutpain.com.au/newswire?rkey=20230802IO73071&filter=7762

https://aboutpain.com.au/newswire?rkey=20230802EN73071&filter=7762

https://pr.rswliving.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.norwoodtownnews.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.herrimanjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://pr.millcreekjournal.com/article/Atherosclerosis-Market-to-Witness-Growth-by-2032-Estimates-DelveInsight-or-Leading-Companies-CSL-Behring-Novartis-Merck-Amgen-Ionis-BioMarin-AstraZeneca?storyId=64cac4aad3c954e138b54d2e

https://thenews.qa/pr-newswire/?rkey=20230802EN73071&filter=25003

#Atherosclerosismarket #Atherosclerosismarketshare #Atherosclerosis #Atherosclerosismarketsize #healthcareblog #consultingblog

0 notes

drramjimehrotra · 1 year ago

Text

Dr. Ramji Mehrotra | Cardiac CT Scan

Cardiac computed tomography (CT) scan, also known as cardiac CT angiography or CTA, is a cutting-edge diagnostic tool that provides detailed images of the heart and its blood vessels. This non-invasive imaging technique has revolutionized the field of cardiology by offering unparalleled insights into the structure and function of the heart.

Uses of Cardiac CT Scan

According to Dr. Ramji Mehrotra, leading cardiovascular surgeon in the NCR region, there are several uses of the Cardiac CT scan including:

Coronary Artery Disease (CAD) Assessment: One of the primary applications of cardiac CT is the evaluation of coronary arteries. It helps identify blockages, stenosis, or plaques within these vital blood vessels that supply oxygen and nutrients to the heart muscle. This is particularly important for diagnosing CAD, a leading cause of heart disease.

Calcium Scoring: Cardiac CT scans can measure the amount of calcium buildup in the coronary arteries, a significant risk factor for heart disease. A high calcium score indicates a higher risk of heart-related events.

Congenital Heart Abnormalities: Cardiac CT is instrumental in detecting and assessing congenital heart defects or abnormalities in adults and children. It helps cardiologists plan surgeries or interventions.

Assessment of Cardiac Anatomy: These scans offer detailed anatomical information about the heart's chambers, valves, and the aorta. This aids in diagnosing conditions like heart valve disease or aortic aneurysms.

Cardiac CT Procedure

A cardiac CT scan involves several key steps:

Patient Preparation: Before the procedure, patients may be asked to abstain from eating or drinking for a specified period. It is important to inform the healthcare team about any allergies or pre-existing medical conditions.

Contrast Injection: A contrast dye is injected into a vein to enhance the visibility of blood vessels and heart structures in the images.

Scanning: The patient lies on a table that moves into the CT scanner, which resembles a large donut-shaped machine. During the scan, X-ray technology and detectors capture multiple cross-sectional images of the heart.

Breath-Holding and Monitoring: Patients are asked to hold their breath for short periods to minimize motion artifacts in the images. Medical personnel closely monitor vital signs throughout the procedure.

Data Processing: Advanced computer software processes the collected data to create detailed, three-dimensional images of the heart and surrounding structures.

Benefits of Cardiac CT Scan

Non-Invasiveness: Unlike traditional angiography, cardiac CT is non-invasive and does not require catheter insertion into blood vessels, reducing the risk of complications and recovery time.

High Resolution: Cardiac CT provides exceptionally high-resolution images, allowing precise diagnosis and treatment planning.

Speed: The procedure is relatively quick, typically taking less than 30 minutes, and patients can usually return to their daily activities afterwards.

Early Detection: It can identify heart conditions at an early stage, enabling timely interventions and improved outcomes.

Conclusion

Dr Ramji Mehrotra is of the opinion that Cardiac CT scans have become an indispensable tool in the field of cardiology, providing a comprehensive view of the heart's structure and function. They play a crucial role in diagnosing and managing various heart conditions, from coronary artery disease to congenital abnormalities. As technology continues to advance, cardiac CT scans are expected to become even more precise and informative, further improving the care and outcomes for patients with heart-related issues.

0 notes